Michelle K. Clements

2.6k total citations
12 papers, 1.2k citations indexed

About

Michelle K. Clements is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Michelle K. Clements has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Michelle K. Clements's work include Ion channel regulation and function (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Pain Mechanisms and Treatments (4 papers). Michelle K. Clements is often cited by papers focused on Ion channel regulation and function (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Pain Mechanisms and Treatments (4 papers). Michelle K. Clements collaborates with scholars based in United States, Canada and United Kingdom. Michelle K. Clements's co-authors include Qingyun Liu, Christopher P. Austin, David L. Williams, Terrence P. McDonald, Ruiping Wang, P. Jeffrey Conn, Gene G. Kinney, Julie A. O’Brien, David J. Figueroa and Jilly F. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Michelle K. Clements

12 papers receiving 1.1k citations

Peers

Countries citing papers authored by Michelle K. Clements

Since Specialization

Citations

This map shows the geographic impact of Michelle K. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle K. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle K. Clements more than expected).

Fields of papers citing papers by Michelle K. Clements

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle K. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle K. Clements. The network helps show where Michelle K. Clements may publish in the future.

Co-authorship network of co-authors of Michelle K. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle K. Clements. A scholar is included among the top collaborators of Michelle K. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle K. Clements. Michelle K. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Humanized NaV1.8 rats overcome cross-species potency shifts in developing novel NaV1.8 inhibitors 2025 ·PubMed ·(unknown), Joshua D. Vardigan, Xiaoping Zhou, Thomas W. Rosahl, Heather Zhou, Eric A. Price, Michelle K. Clements, Yuxing Li, (unknown), (unknown), Shawn J. Stachel, Michael J. Breslin, Christopher S. Burgey, Richard L. Kraus, (unknown), Darrell A. Henze, Vincent P. Santarelli	1
2	2-Aminopyridines as Potent and Selective Na_v1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model 2024 ·ACS Medicinal Chemistry Letters ·Michael J. Breslin, (unknown), Deping Wang, Chien-Jung Huang, Michelle K. Clements, Yuxing Li, Xiaoping Zhou, Joshua D. Vardigan, Richard L. Kraus, Vincent P. Santarelli, Jason M. Uslaner, Paul J. Coleman, Shawn J. Stachel	3
3	Analgesia and peripheral c-fiber modulation by selective Nav1.8 inhibition in rhesus 2024 ·Pain ·Joshua D. Vardigan, (unknown), (unknown), Chien-Jung Huang, Michelle K. Clements, Yuxing Li, Richard L. Kraus, Michael J. Breslin, Christopher J. Bungard, (unknown), (unknown), (unknown), M. E. Layton, Shawn J. Stachel, Henry S. Lange, Alan T. Savitz, Vincent P. Santarelli, Darrell A. Henze, Jason M. Uslaner	3
4	Discovery of Arylsulfonamide Na _v 1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile 2021 ·ACS Medicinal Chemistry Letters ·Anthony J. Roecker, M. E. Layton, (unknown), Michael J. Kelly, Thomas J. Greshock, Richard L. Kraus, Yuxing Li, Rebecca M. Klein, Michelle K. Clements, Christopher J. A. Daley, Aneta Jovanovska, Jeanine Ballard, Deping Wang, Fuqiang Zhao, Andrew P. J. Brunskill, Xuanjia Peng, Xiu Wang, Haiyan Sun, Andrea K. Houghton, Christopher S. Burgey	8
5	Na _v 1.7 target modulation and efficacy can be measured in nonhuman primate assays 2021 ·Science Translational Medicine ·Richard L. Kraus, Fuqiang Zhao, (unknown), Dan Zhou, Joshua D. Vardigan, Andrew Danziger, Yuxing Li, Christopher J. A. Daley, Jeanine Ballard, Michelle K. Clements, Rebecca M. Klein, Marie A. Holahan, Thomas J. Greshock, Ronald M. Kim, M. E. Layton, Christopher S. Burgey, Jordi Serra, Darrell A. Henze, Andrea K. Houghton	15
6	Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5 2016 ·SLAS DISCOVERY ·Michael Finley, (unknown), (unknown), (unknown), Kelli Solly, (unknown), Michelle K. Clements, Antonella Converso, Sean P. Cook, (unknown), Richard L. Kraus, Ming‐Tain Lai, M. E. Layton, Wei Lemaire, (unknown), Jixin Wang	5
7	A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Gene G. Kinney, Julie A. O’Brien, Wei Lemaire, Maryann Burno, (unknown), Michelle K. Clements, Tsing‐Bau Chen, David D. Wisnoski, Craig W. Lindsley, Philip R. Tiller, Sheri Smith, Marlene A. Jacobson, Cyrille Sur, Mark E. Duggan, Douglas J. Pettibone, P. Jeffrey Conn, David L. Williams	229
8	Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment 2003 ·Proceedings of the National Academy of Sciences ·Michael J. Marino, David L. Williams, Julie A. O’Brien, Ornella Valenti, Terrence P. McDonald, Michelle K. Clements, Ruiping Wang, Anthony G. DiLella, J. Fred Hess, Gene G. Kinney, P. Jeffrey Conn	198
9	Identification, localization and receptor characterization of novel mammalian substance P-like peptides 2002 ·Gene ·Marc M. Kurtz, Ruiping Wang, Michelle K. Clements, Margaret A. Cascieri, Christopher P. Austin, Barry R. Cunningham, Gary G. Chicchi, Qingyun Liu	137
10	Expression of the Cysteinyl Leukotriene 1 Receptor in Normal Human Lung and Peripheral Blood Leukocytes 2001 ·American Journal of Respiratory and Critical Care Medicine ·David J. Figueroa, Richard Breyer, (unknown), Stacia Kargman, Bruce L. Daugherty, K E Waldburger, Qingyun Liu, Michelle K. Clements, (unknown), Gary P. O’Neill, Thomas R. Jones, Kevin R. Lynch, Christopher P. Austin, Jilly F. Evans	225
11	FMRFamide-Related Neuropeptides Are Agonists of the Orphan G-Protein-Coupled Receptor GPR54 2001 ·Biochemical and Biophysical Research Communications ·Michelle K. Clements, Terrence P. McDonald, Ruiping Wang, Guochun Xie, Brian F. O’Dowd, Susan R. George, Christopher P. Austin, Qingyun Liu	96
12	Identification and Characterization of Novel Mammalian Neuropeptide FF-like Peptides That Attenuate Morphine-induced Antinociception 2001 ·Journal of Biological Chemistry ·Qingyun Liu, Xiao Ming Guan, William J. Martin, Terrence P. McDonald, Michelle K. Clements, Qingping Jiang, Zhizhen Zeng, Marlene A. Jacobson, David L. Williams, Hong Yu, (unknown), David J. Figueroa, John Mallee, Ruiping Wang, Jilly F. Evans, Robert J. Gould, Christopher P. Austin	233

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact